Human Hyaluronan-binding protein 2(HABP2) ELISA kit
Product Details
| Target Name |
hyaluronan binding protein 2 |
| Alternative Names |
Factor seven activating protease ELISA Kit; Factor seven-activating protease ELISA Kit; Factor VII activating protein ELISA Kit; Factor VII-activating protease ELISA Kit; FSAP ELISA Kit; HABP 2 ELISA Kit; HABP ELISA Kit; Habp2 ELISA Kit; HABP2_HUMAN ELISA Kit; Hepatocyte growth factor activator like protein ELISA Kit; Hepatocyte growth factor activator-like protein ELISA Kit; HGFAL ELISA Kit; Hyaluronan binding protein 2 ELISA Kit; Hyaluronan-binding protein 2 27 kDa light chain alternate form ELISA Kit; Hyaluronic acid binding protein 2 ELISA Kit; PHBP ELISA Kit; Plasma hyaluronan binding protein ELISA Kit; Plasma hyaluronan-binding protein ELISA Kit |
| Abbreviation |
HABP2 |
| Species |
Homo sapiens (Human) |
| Sample Types |
serum, plasma, tissue homogenates |
| Detection Range |
0.312 ng/mL-20 ng/mL |
| Sensitivity |
0.078 ng/mL |
| Assay Time |
1-5h |
| Sample Volume |
50-100ul |
| Detection Wavelength |
450 nm |
| Research Area |
Cardiovascular |
| Assay Principle |
quantitative |
| Measurement |
Sandwich |
| Precision |
| Intra-assay Precision (Precision within an assay): CV% |
| Three samples of known concentration were tested twenty times on one plate to assess. |
|
| Inter-assay Precision (Precision between assays): CV% |
| Three samples of known concentration were tested in twenty assays to assess. |
|
|
| |
|
|
|
|
|
|
|
| Linearity |
| To assess the linearity of the assay, samples were spiked with high concentrations of human HABP2 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. |
| |
Sample |
Serum(n=4) |
|
| 1:20 |
Average % |
88 |
|
| Range % |
82-96 |
|
| 1:40 |
Average % |
89 |
|
| Range % |
85-95 |
|
| 1:80 |
Average % |
96 |
|
| Range % |
91-101 |
|
| 1:160 |
Average % |
100 |
|
| Range % |
97-103 |
|
|
| Recovery |
| The recovery of human HABP2 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. |
| Sample Type |
Average % Recovery |
Range |
|
| Serum (n=5) |
103 |
99-105 |
|
| EDTA plasma (n=4) |
92 |
85-98 |
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| Typical Data |
| These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. |
| ng/ml |
OD1 |
OD2 |
Average |
Corrected |
|
| 20 |
2.875 |
2.775 |
2.825 |
2.725 |
|
| 10 |
2.524 |
2.345 |
2.435 |
2.335 |
|
| 5 |
1.818 |
1.787 |
1.803 |
1.703 |
|
| 2.5 |
0.964 |
0.901 |
0.933 |
0.833 |
|
| 1.25 |
0.602 |
0.586 |
0.594 |
0.494 |
|
| 0.625 |
0.400 |
0.425 |
0.413 |
0.313 |
|
| 0.312 |
0.205 |
0.195 |
0.200 |
0.100 |
|
| 0 |
0.101 |
0.098 |
0.100 |
|
|
|
|
| Storage |
Store at 2-8°C. Please refer to protocol. |
| Lead Time |
7-14 working days |
